Medbright AI Investments Inc (MBAIF)

[gramara]

Some info from the most recent form 7. Not much new:

As per the previous Form 7 disclosure the Company continues to undergo its fundamental business change, therefore public trading of its shares remains halted.

The Company had received approval from the listing committee of the CSE for its fundamental change of business. However, with the company signing a letter of intent with Phyto Pharma it is required to amend the listing statement to reflect the new transaction.

The Company has completed the amended listing statement and submitted it to the CSE.